nach oben

Osteoporosis International

Erschienen in:

17.11.2016 | Original Article

Trends in hip fracture rates in Taiwan: a nationwide study from 1996 to 2010

verfasst von: T.Y. Wu, H.Y. Hu, S.Y. Lin, W.C. Chie, R.S. Yang, C.K. Liaw

Erschienen in: Osteoporosis International | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Summary

There was an initial increase and a later decrease in hip fracture rates in Taiwan between 1996 and 2010 (457.9 to 390.0 fractures per 100,000 people per year). Mortality rates decreased but re-emerged later (2.26 to 1.91 deaths per 100 hip fracture admissions). The turning point for change in trends was 2003.

Introduction

Fractures of the proximal femur remain a major cause of mortality and morbidity. We aimed to examine recent trends in hip fracture rates, in-hospital mortality rates, and length of hospital stay (LOS) due to hip fractures in people aged 55 and over in Taiwan.

Methods

This is a time-trend study. We used data from the National Health Insurance Research Database between 1996 and 2010 in Taiwan. Insurants aged 55 and over were included. The outcome measures were age-adjusted hip fracture rates, age-adjusted in-hospital mortality rates, and LOS due to hip fractures. We classified hip fractures into femoral neck, trochanteric, and subtrochanteric fractures.

Results

We identified 250,919 hospitalizations for hip fractures. The total number of hip fractures increased steadily from 12,479 to 19,841 cases. There was a trend towards initial increase and then later decrease in hip fracture rates (from 457.9 to 390.0 fractures per 100,000 people per year). LOS decreased by 46.5 % (17.53 to 9.38 days). By contrast, mortality rates for hip fractures decreased initially, but re-emerged later with a total decrement of 15.5 % (2.26 to 1.91 deaths per 100 hip fracture admissions). Women outnumbered men in all types of hip fractures, but men had higher in hospital mortality rates. LOS was similar between genders and among age groups. The turning point for change in trends was year 2003.

Conclusions

While LOS shortened gradually since 1996, the absolute number of hip fractures in Taiwan continues to rise. There is still room for improvement in reducing mortality due to hip fractures.

Nur mit Berechtigung zugänglich

Crandall CJ, Newberry SJ, Diamant A, Lim YW, Gellad WF, Booth MJ, Motala A, Shekelle PG (2014) Comparative effectiveness of pharmacologic treatments to prevent fractures: an updated systematic review. Ann Intern Med 161:711–723. doi:10.7326/M14-0317 CrossRefPubMed

Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17(12):1726–1733. doi:10.1007/s00198-006-0172-4 CrossRefPubMed

Huang YF, Liang J, Shyu YI (2014) Ageism perceived by the elderly in Taiwan following hip fracture. Arch Gerontol Geriatr 58(1):30–36. doi:10.1016/j.archger.2013.08.009 CrossRefPubMed

Yang NP, Chan CL, Yu IL, Lee CY, Chou P (2010) Estimated prevalence of orthopaedic fractures in Taiwan—a cross-sectional study based on nationwide insurance data. Injury 41(12):1266–1272. doi:10.1016/j.injury.2010.05.025 CrossRefPubMed

Rao SS, Cherukuri M (2006) Management of hip fracture: the family physician’s role. Am Fam Physician 73(12):2195–2200. doi:10.3810/hp.2011.02.374 PubMed

Chevalley T, Guilley E, Herrmann FR, Hoffmeyer P, Rapin CH, Rizzoli R (2007) Incidence of hip fracture over a 10-year period (1991-2000): reversal of a secular trend. Bone 40(5):1284–1289. doi:10.1016/j.bone.2006.12.063 CrossRefPubMed

Kanis JA, Oden A, McCloskey EV, Johansson H, Wahl DA, Cooper C, IOF Working Group on Epidemiology and Quality of Life (2012) A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int 23(9):2239–2256. doi:10.1007/s00198-012-1964-3 CrossRefPubMedPubMedCentral

Kanis JA, Johnell O, De Laet C, Jonsson B, Oden A, Ogelsby AK (2002) International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res 17(7):1237–1244. doi:10.1359/jbmr.2002.17.7.1237 CrossRefPubMed

Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB (2009) Incidence and mortality of hip fractures in the United States. JAMA 302(14):1573–1579. doi:10.1001/jama.2009.1462 CrossRefPubMedPubMedCentral

10.

Chau PH, Wong M, Lee A, Ling M, Woo J (2013) Trends in hip fracture incidence and mortality in Chinese population from Hong Kong 2001–09. Age Ageing 42(2):229–233. doi:10.1093/ageing/afs177 CrossRefPubMed

11.

Ohta H, Mouri M, Kuroda T, Nakamura T, Shiraki M, Orimo H (2016) Decreased rate of hip fracture and consequent reduction in estimated medical costs in Japan. J Bone Miner Metab doi. doi:10.1007/s00774-016-0760-0

12.

Wang CB, Lin CF, Liang WM, Chen CF, Chang YJ, Wu HC, Wu TN, Leu TH (2013) Excess mortality after hip fracture among the elderly in Taiwan: a nationwide population-based cohort study. Bone 56(1):147–153. doi:10.1016/j.bone.2013.05.015 CrossRefPubMed

13.

Chan DC, Lee YS, Wu YJ, Tsou HH, Chen CT, Hwang JS, Tsai KS, Yang RS (2013) A 12-year ecological study of hip fracture rates among older Taiwanese adults. Calcif Tissue Int 93(5):397–404. doi:10.1007/s00223-013-9759-x CrossRefPubMed

14.

Committee for Osteoporosis Treatment of The Japanese Orthopaedic Association (2004) Nationwide survey of hip fractures in Japan. J Orthop Sci 9(1):1–5. doi:10.1007/s00776-003-0741-8 CrossRef

15.

Shao CJ, Hsieh YH, Tsai CH, Lai KA (2009) A nationwide seven-year trend of hip fractures in the elderly population of Taiwan. Bone 44(1):125–129. doi:10.1016/j.bone.2008.09.004 CrossRefPubMed

16.

Karaeminogullari O, Demirors H, Atabek M, Tuncay C, Tandogan R, Ozalay M (2004) Avascular necrosis and nonunion after osteosynthesis of femoral neck fractures: effect of fracture displacement and time to surgery. Adv Ther 21:335–342. doi:10.1007/BF02850038 CrossRefPubMed

17.

Rodriguez-Merchan EC (2002) In situ fixation of nondisplaced intracapsular fractures of the proximal femur. Clin Orthop Relat Res 42–51

18.

Damany DS, Parker MJ, Chojnowski A (2005) Complications after intracapsular hip fractures in young adults. A meta-analysis of 18 published studies involving 564 fractures. Injury 36:131–141. doi:10.1016/j.injury.2004.05.023 PubMed

19.

National Health Insurance Administration, Taiwan (2015) New Era of National Health Insurance. National Health Insurance Administration, Ministry of Health and Welfare, Taiwan. http://www.nhi.gov.tw/webdata/webdata.aspx?menu=17&menu_id=659&webdata_id=4518 Accessed 1 Sep 2015

20.

Lin WP, Wen CJ, Jiang CC, Hou SM, Chen CY, Lin J (2011) Risk factors for hip fracture sites and mortality in older adults. J Trauma 71(1):191–197. doi:10.1097/TA.0b013e31821f4a34 CrossRefPubMed

21.

Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19:335–351. doi:10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z CrossRefPubMed

22.

Huang KY, Chang JK, Ling SY, Endo N, Takahashi HE (2000) Epidemiology of cervical and trochanteric fractures of the proximal femur in 1996 in Kaohsiung City, Taiwan. J Bone Miner Metab 18(2):89–95. doi:10.1007/s007740050017 CrossRefPubMed

23.

Lai YS, Wei HW, Cheng CK (2008) Incidence of hip replacement among national health insurance enrollees in Taiwan. J Orthop Surg Res 3:42. doi:10.1186/1749-799X-3-42 CrossRefPubMedPubMedCentral

24.

Chen IJ, Chiang CY, Li YH et al (2015) Nationwide cohort study of hip fractures: time trends in the incidence rates and projections up to 2035. Osteoporos Int 26(2):681–688. doi:10.1007/s00198-014-2930-z CrossRefPubMed

25.

Chie WC, Yang RS, Liu JP, Tsai KS (2004) High incidence rate of hip fracture in Taiwan: estimated from a nationwide health insurance database. Osteoporos Int 15(12):998–1002. doi:10.1007/s00198-004-1651-0 CrossRefPubMed

26.

Kannegaard PN, van der Mark S, Eiken P, Abrahamsen B (2010) Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival. Age Ageing 39(2):203–209. doi:10.1093/ageing/afp221 CrossRefPubMed

27.

Cooper C, Cole ZA, Holroyd CR, Earl SC, Harvey NC, Dennison EM, Melton LJ, Cummings SR, Kanis JA (2011) Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int 22(5):1277–1288. doi:10.1007/s00198-011-1601-6 CrossRefPubMedPubMedCentral

28.

Jaglal SB, Weller I, Mamdani M, Hawker G, Kreder H, Jaakkimainen L, Adachi JD (2004) Population trends in BMD testing, treatment, and hip and wrist fracture rates: are the hip fracture projections wrong? J Bone Miner Res 20(6):898–905. doi:10.1359/JBMR.041231 CrossRefPubMed

29.

Makridis KG, Karachalios T, Kontogeorgakos VA, Badras LS, Malizos KN (2015) The effect of osteoporotic treatment on the functional outcome, re-fracture rate, quality of life and mortality in patients with hip fractures: a prospective functional and clinical outcome study on 520 patients. Injury 46(2):378–383. doi:10.1016/j.injury.2014.11.031 CrossRefPubMed

30.

Hawley S, Leal J, Delmestri A, Prieto-Alhambra D, Arden NK, Cooper C, Javaid MK, Judge A, Group RES (2016) Anti-osteoporosis medication prescriptions and incidence of subsequent fracture among primary hip fracture patients in England and Wales: an interrupted time-series analysis. J Bone Miner Res. doi:10.1002/jbmr.2882

31.

Makras P, Delaroudis S, Anastasilakis AD (2015) Novel therapies for osteoporosis. Metabolism 64:1199–1214. doi:10.1016/j.metabol.2015.07.011 CrossRefPubMed

32.

Reginster JY, Neuprez A, Dardenne N, Beaudart C, Emonts P, Bruyere O (2014) Efficacy and safety of currently marketed anti-osteoporosis medications. Best Pract Res Clin Endocrinol Metab 28:809–834. doi:10.1016/j.beem.2014.09.003 CrossRefPubMed

33.

Beall DP, Feldman RG, Gordon ML, Gruber BL, Lane JM, Valenzuela G, Yim D, Alam J, Krege JH, Krohn K (2016) Patients with prior vertebral or hip fractures treated with teriparatide in the direct assessment of nonvertebral fractures in community experience (DANCE) observational study. Osteoporos Int 27:1191–1198. doi:10.1007/s00198-015-3353-1 CrossRefPubMed

34.

Bawa HS, Weick J, Dirschl DR (2015) Anti-osteoporotic therapy after fragility fracture lowers rate of subsequent fracture: analysis of a large population sample. J Bone Joint Surg Am 97:1555–1562. doi:10.2106/jbjs.n.01275 CrossRefPubMed

35.

Leslie WD, O’Donnell S, Jean S, Lagace C, Walsh P, Bancej C, Morin S, Hanley DA, Papaioannou A (2009) Trends in hip fracture rates in Canada. JAMA 302(8):883–889. doi:10.1001/jama.2009.1231 CrossRefPubMed

36.

Ferrari S, Adachi JD, Lippuner K et al (2015) Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years. Osteoporos Int 26:2763–2771. doi:10.1007/s00198-015-3179-x CrossRefPubMedPubMedCentral

37.

Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA, Manitoba Bone Density P (2012) Does osteoporosis therapy invalidate FRAX for fracture prediction? J Bone Miner Res 27:1243–1251. doi:10.1002/jbmr.1582 CrossRefPubMed

38.

Vestergaard P, Rejnmark L, Mosekilde L (2007) Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complications. Osteoporos Int 18(12):1583–1593. doi:10.1007/s00198-007-0403-3 CrossRefPubMed

39.

Rostagno C, Buzzi R, Campanacci D et al (2016) In hospital and 3-month mortality and functional recovery rate in patients treated for hip fracture by a multidisciplinary team. PLoS One 11:e0158607. doi:10.1371/journal.pone.0158607 CrossRefPubMedPubMedCentral

40.

Prodovic T, Ristic B, Rancic N, Bukumiric Z, Zeljko S, Ignjatovic-Ristic D (2016) Factors influencing the six-month mortality rate in patients with a hip fracture. Zdr Varst 55:102–107. doi:10.1515/sjph-2016-0015 PubMed

41.

Ricci G, Longaray MP, Goncalves RZ, Neto Ada S, Manente M, Barbosa LB (2012) Evaluation of the mortality rate one year after hip fracture and factors relating to diminished survival among elderly people. Rev Bras Ortop 47:304–309. doi:10.1016/S2255-4971(15)30103-8 CrossRefPubMed

42.

Ariza-Vega P, Kristensen MT, Martin-Martin L, Jimenez-Moleon JJ (2015) Predictors of long-term mortality in older people with hip fracture. Arch Phys Med Rehabil. doi:10.1016/j.apmr.2015.01.023 PubMed

43.

Bretherton CP, Parker MJ (2015) Early surgery for patients with a fracture of the hip decreases 30-day mortality. Bone Joint J 97-B(1):104–108. doi:10.1302/0301-620X.97B1.35041 CrossRefPubMed

44.

Mariconda M, Costa GG, Cerbasi S, Recano P, Aitanti E, Gambacorta M, Misasi M (2015) The determinants of mortality and morbidity during the year following fracture of the hip: a prospective study. Bone Joint J 97-B(3):383–390. doi:10.1302/0301-620X.97B3.34504 CrossRefPubMed

45.

Bottle A, Aylin P (2006) Mortality associated with delay in operation after hip fracture: observational study. BMJ 332(7547):947–951. doi:10.1136/bmj.38790.468519.55 CrossRefPubMedPubMedCentral

46.

Gehlbach SH, Avrunin JS, Puleo E (2007) Trends in hospital care for hip fractures. Osteoporos Int 18(5):585–591. doi:10.1007/s00198-006-0281-0 CrossRefPubMed

47.

Chatterton BD, Moores TS, Ahmad S, Cattell A, Roberts PJ (2015) Cause of death and factors associated with early in-hospital mortality after hip fracture. Bone Joint J 97-B(2):246–251. doi:10.1302/0301-620X.97B2.35248 CrossRefPubMed

48.

Ha YC, Park YG, Nam KW, Kim SR (2015) Trend in hip fracture incidence and mortality in Korea: a prospective cohort study from 2002 to 2011. J Korean Med Sci 30(4):483–488. doi:10.3346/jkms.2015.30.4.483 CrossRefPubMedPubMedCentral

49.

Tinetti ME, Baker DI, King M, Gottschalk M, Murphy TE, Acampora D, Carlin BP, Leo-Summers L, Allore HG (2008) Effect of dissemination of evidence in reducing injuries from falls. N Engl J Med 359(3):252–261. doi:10.1056/NEJMoa0801748 CrossRefPubMedPubMedCentral

50.

Sakuma M, Endo N, Oinuma T, Endo E, Yazawa T, Watanabe K, Watanabe S (2008) Incidence and outcome of osteoporotic fractures in 2004 in Sado City, Niigata prefecture, Japan. J Bone Miner Metab 26(4):373–378. doi:10.1007/s00774-007-0841-1 CrossRefPubMed

51.

Sund R, Liski A (2005) Quality effects of operative delay on mortality in hip fracture treatment. Qual Saf Health Care 14(5):371–377. doi:10.1136/qshc.2004.012831 CrossRefPubMedPubMedCentral

52.

Hung WW, Egol KA, Zuckerman JD, Siu AL (2012) Hip fracture management: tailoring care for the older patient. JAMA 307(20):2185–2194. doi:10.1001/jama.2012.4842 CrossRefPubMed

53.

Sobolev B, Sheehan KJ, Kuramoto L, Guy P (2015) Excess mortality associated with second hip fracture. Osteoporos Int 26(7):1903–1910. doi:10.1007/s00198-015-3104-3 CrossRefPubMed

Titel: Trends in hip fracture rates in Taiwan: a nationwide study from 1996 to 2010
verfasst von: T.Y. Wu
H.Y. Hu
S.Y. Lin
W.C. Chie
R.S. Yang
C.K. Liaw
Publikationsdatum: 17.11.2016
Verlag: Springer London
Erschienen in: Osteoporosis International / Ausgabe 2/2017
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-016-3783-4

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

25.04.2024 | Hypertonie | Nachrichten

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Trends in hip fracture rates in Taiwan: a nationwide study from 1996 to 2010

Abstract

Summary

Introduction

Methods

Results

Conclusions

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Ärztliche Empathie hilft gegen Rückenschmerzen

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Update Orthopädie und Unfallchirurgie

Springer Medizin

Abstract

Summary

Introduction

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2017

Hypocalcaemia after denosumab in older people following fracture

A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women

Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study

Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients

Impact of level of expertise versus the statistical tool on vertebral fracture assessment (VFA) readings in cohort studies

Further major uncorrected errors in National Osteoporosis Foundation meta-analyses of calcium and vitamin D supplementation in fracture prevention

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Ärztliche Empathie hilft gegen Rückenschmerzen

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Update Orthopädie und Unfallchirurgie